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Background: Endometrium undergoes dramatic growth, breakdown and regeneration throughout reproductive
period in mammals. Stem cells have been implicated in the process however their origin, nature, anatomical
localization and characterization still remain obscure. Classical concept of presence of stem cells in the basal layer
of endometrium was recently challenged when side population and label retaining cells were found to be distributed
throughout endometrium. We have earlier reported very small embryonic-like stem cells (VSELs) in adult mammalian
ovary and testis as a small population of cells with nuclear OCT-4 along with progenitors (spermatogonial stem cells
and ovarian germ stem cells) with cytoplasmic OCT-4. Present study was undertaken to gauge presence of VSELs in
bilaterally ovariectomized mouse uterus and their modulation by hormones.
Methods: Bilaterally ovariectomized mice were subjected to sequential estradiol and progesterone treatment in order
to induce proliferation, differentiation and remodeling (regeneration). Stem cells were studied in tissue smears after H &
E staining and after sorting using SCA-1 by immuno-localization and qRT-PCR studies (Oct-4A, Nanog and Sca-1). Flow
cytometry studies were also undertaken to confirm the presence of VSELs in mouse uterus.
Results: Two distinct populations of stem cells with dark stained nucleus and high nucleo-cytoplasmic ratio were
detected in ovariectomized mouse uterus. These cells were sorted using SCA-1 and comprised smaller VSELs with
nuclear expression of OCT-4 and slightly bigger, more abundant progenitors termed as endometrial stem cells
(EnSCs) with cytoplasmic OCT-4. RT-PCR studies showed presence of pluripotent transcripts (Oct-4, Sca-1) and flow
cytometry confirmed the presence of 0.069% of LIN-/CD45-/SCA-1+ VSELs. These stem cells were distinctly regulated
during endometrial growth, differentiation and regeneration as evidenced by qRT-PCR results.
Conclusions: VSELs are present in normal uterus and also under conditions of atrophy induced by bilateral
ovariectomy. Marked increase in EnSCs is associated with endometrial growth and regeneration. Further studies
are warranted to define the niche for these stem cells and whether EnSCs arising from the pluripotent VSELs are
common progenitors for epithelial and stromal cells or not remains to be addressed. Results of the present study
will help in better understanding of endometrial pathologies and their management in the future.
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A novel population of pluripotent stem cells termed very
small embryonic-like stem cells exists in various adult
body organs as shown by seminal contributions made by
Ratajczak’s group [1,2]. These cells are believed to be the
primordial germ cells or their precursors which while
migrating to the gonadal ridges via the dorsal mesentery
during early embryonic development, possibly migrate* Correspondence: deepa.bhartiya@yahoo.in
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unless otherwise stated.to various developing body organs and persist through-
out life as a backup population of pluripotent stem cells
to maintain tissue homeostasis [3-5]. VSELs are very
small in size (smaller than red blood cells), have a char-
acteristic spherical shape, high nucleo-cytoplasmic ratio,
exhibit intensely Hematoxylin stained large nucleus sur-
rounded by a thin rim of cytoplasm, are positive for
alkaline phosphatase, can be isolated in mice as LIN-/
CD45-/SCA-1+ cells by flow cytometry, express pluripo-
tent transcripts including nuclear Oct-4, Nanog, Sox-2
and cell surface SSEA-1 and have long telomeres. VSELsThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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potential to differentiate into all three germ layers in
mice [6] and humans [7], however; unlike pluripotent
embryonic stem cells, they do not form teratoma nor
compliment developing embryos. This is due to the
novel epigenetic mechanism of imprint erasure on pater-
nally imprinted DMRs (H19-Igf2, RasGRF1) exhibited by
VSELs [3,8] as they appear slightly later during embry-
onic development (in epiblast-stage embryo) compared
to ES cells derived in vitro from the inner cell mass. ES
cells undergo symmetric cell divisions in vitro, are im-
mortal in nature, form teratoma and compliment devel-
oping embryo in contrast to VSELs which exhibit
extreme quiescence in vitro and possibly undergo asym-
metric cell divisions in vivo to self-renew and give rise
to progenitors which expand in large numbers and fur-
ther differentiate into specific cell types depending on
their location.
We have reported relatively quiescent, pluripotent
VSELs with nuclear OCT-4 in adult mammalian testis
and ovary [9,10]. Besides VSELs, there exists another
population of tissue specific progenitors derived from
the VSELs which are slightly bigger in size, have cyto-
plasmic OCT-4 and are more active including spermato-
gonial stem cells (SSCs) in testis and ovarian germ stem
cells (OGSCs) in ovary. This existence of two stem cells
populations in gonads is in agreement with similar con-
cept of quiescent and active stem cell populations pro-
posed in bone marrow, skin and gut [11,12]. Stem cells
are lodged in the ovary surface epithelium and in the
testicular seminiferous epithelium. VSELs have remained
elusive so far because of their very small size and are
not easily visualized in paraffin sections; rather we first de-
tected them in smears prepared after enzymatic digestion
of the gonadal tissue. VSELs located in the ovary surface
epithelium express gonadotropin (follicle-stimulating hor-
mone, FSH) receptors and undergo self-renewal and germ
cell nest formation after FSH treatment [13-16]. Similarly,
Kucia et al. [3] reported that bone marrow VSELs express
mRNA for several pituitary and gonadal hormone recep-
tors and administration of sex hormones directly stimu-
lates expansion (∼2–3x) of VSELs and HSCs in bone
marrow associated with increased BrdU incorporation.
Because of their quiescent nature, VSELs survive total
body radiation in mouse bone marrow (HSCs are
destroyed) [17] and also chemotherapy in mice testes
(SSCs, spermatocytes and haploid sperm get destroyed)
[18] and ovaries (OGSCs, follicles get destroyed) [19].
On providing a healthy microenvironment (by way
of inter-tubular transplantation of healthy Sertoli or
mesenchymal cells) resulted in restoration of spermato-
genesis in chemoablated testis [18]. Similarly the VSELs
in chemoablated ovaries retain potential to initiate neo-
oogenesis and germ cells cluster formation [19].Present study was undertaken to investigate whether
similar populations of VSELs and endometrium specific
progenitors exist in the mouse uterus and if they do,
whether they are modulated by sex hormones. Uterine
endometrium is a dynamic tissue in the body which under-
goes regular proliferation, differentiation, growth, break-
down and shedding and again regenerates more than 400
times during the reproductive life in humans [20]. After the
endometrium is shed as part of the physiologic, normal
28 days menstrual cycle, it regenerates to a thickness of
4-7 mm within 4-10 days [21]. Besides it also undergoes
extensive growth during pregnancy to accommodate the
growing fetus and following hormone replacement therapy
in menopausal women. Stem cells have been implicated in
the process of endometrium remodeling, regeneration and
also during various disease conditions like endometriosis
and endometrial hyperplasia, carcinoma, leiomyomas and
adenomyosis [22]. Data is now emerging using various
approaches on endometrial stem cells and their possible
location however, a clear consensus on their origin, nature,
anatomical location and character is still lacking [23].
Bilaterally ovariectomized mice model has been used
in the present study as it allows manipulation of endo-
metrial cells in response to the steroids administered
and has been used by various investigators in the past
[24-26]. This model was recently used as a functional
model of endometrial breakdown and repair [27] that
mimics events of menstruation in women [24,28,29]. It
is intriguing to point out here that pluripotent tran-
scripts have been reported in both mice [30] and human
[31-35] endometrium. However, most of the groups have
reported cytoplasmic OCT-4 which is not crucial for
stemness and has resulted in lot of confusion in the
available literature [36,37]. But since cells with cytoplas-
mic OCT-4 have been reported in the uterus, we specu-
lated that there may also exist a small population of
pluripotent stem cells with nuclear OCT-4A which gives
rise to the cells with cytoplasmic OCT-4. Our study is a
preliminary report and further studies to functionally
characterize the stem cells and their ability to differenti-
ate into glands and stromal cells are ongoing.
Materials and methods
The study was approved by Institute Animal Ethics
Committee and was carried out using in-house bred
eight-weeks old Swiss mice housed in the Experimental
Animal Facility. They were kept in a temperature and
humidity controlled room on a 12 hr light/12 hr dark-
ness cycle with free access to food and water.
Study design
Presence of VSELs in mouse uterus
Despite the presence of VSELs in the ovarian [38] and
testicular [39] smears, they cannot be easily observed in
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these stem cells have been described as the ‘lost pearls’
that are smaller than red blood cells in size and easily get
missed as debris [40]. Thus similar to our earlier efforts of
detecting VSELs in smears and later in sections, whole
uterine tissue was used to prepare smears to search for the
VSELs since we were sure neither of their presence nor
their exact location/niche in uterus. A normal mouse
uterus was used to prepare cell suspension by enzymatic
digestion. Once the VSELs were detected in the smears
and also by flow cytometry as SCA-1 positive cells in the
size range of 3-5 μm, the whole study was planned and
various experiments were undertaken. Detailed enumer-
ation of VSELs in mouse uterus as LIN-/CD45-/SCA-1+
cells was done at the Stem Cell Institute at James Graham
Brown Cancer Center, University of Louisville by PG (refer
to Additional file 1 for details).
Characterization of uterine VSELs
The uterine smears were used to study expression of octa-
mer binding transcription factor (OCT-4) specific for
pluripotent state [41] in VSELs. The cell suspension after
enzymatic digestion was subjected to immuno-magnetic
enrichment of VSELs using SCA-1. Both the positive and
negative SCA-1 sorted fractions were subjected to RT-
PCR to detect presence of pluripotent transcripts includ-
ing Oct-4A (specific for nuclear OCT-4A isoform), Sca-1
(stem cell antigen-1) and Nanog (homeobox transcriptionFigure 1 Treatment schedule and gross appearance of uteri at the tim
how mouse uterine stem cells are modulated by hormones under varying co
regeneration. Mice were bilaterally ovariectomized (on Day 0) and 14 day
received no hormonal treatment, were sacrificed on Day 25 and the uteru
to other groups. Gp B, D & E received estradiol (E, 100 ng/day) priming for six
sacrificed 24 hrs later to study the proliferative effect of estradiol on endomet
(P, 1 mg/day) on Days 21-24 and sacrificed 24 hrs later to study the effect of p
progesterone on Days 21-24 and also estradiol (50 ng) on Day 24, and wa
receptive phase endometrium with maximal growth. Gp E reflected condition
mice were treated as Gp D and were sacrificed 48 hrs after Gp D i.e. on Day 2factor). Oct-4 (representing total Oct-4 inclusive of all
transcripts of Oct-4) transcript which is suggestive of
the presence of VSELs and their immediate descendant
‘progenitors’ was also studied.
Modulation of VSELs by different hormonal conditions
To study whether VSELs are modulated by different
hormonal conditions during endometrial atrophy, pro-
liferation, differentiation and remodeling, the mice
were subjected to bilateral ovariectomy under aseptic
conditions. Fourteen days after bilateral ovariectomy,
mice were divided into 5 groups (Figure 1) including (i)
control OVX group which received only sesame oil
injections (ii) estradiol (E) (iii) progesterone (P) (iv) E + P
(v) 48 hrs after withdrawal of E + P. These different groups
represented uterine atrophy (Gp A); proliferation (ex-
pected after E and not after P treatment, Gp B & C);
secretory phase (E + P group, Gp D) and remodeling
(48 hrs of withdrawal of E + P, Gp E). Various events like
uterine proliferation and apoptosis was confirmed by
qRT-PCR using specific markers. Proliferating cell nuclear
antigen (Pcna) was used as a marker for proliferation. It is
a key cell-cycle regulator and has an important role to play
during DNA repair and replication. Ratio of Bcl-2/Bax
was used to confirm apoptosis. Bcl-2 is a proto-oncogene
and Bax is a pro-apoptotic protein that induces apoptosis
by homodimerization and heterodimerization with Bcl-2.
VSELs specific transcripts (Oct4, Oct4A, Nanog, Sca-1)e of sacrifice. Various treatment groups (Gp) were used to study
nditions of endometrium including atrophy, growth and remodeling/
s later were subjected to various hormonal treatments as shown. Gp A
s appeared atrophied evident by its very thin appearance compared
days (D14-19). Gp B was treated with 50 ng/ml estradiol on Day 25 and
rial cells. Gp C was not primed with estradiol, only received progesterone
rogesterone alone on the endometrium. Gp D received estradiol priming,
s sacrificed 24 hrs after the treatment on Day 25 was the E + P treated
of remodeling/regeneration resulting by withdrawal of hormones. These
7.
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groups to evaluate whether they are differentially modu-
lated under different conditions.
Methods
Bilateral ovariectomy and hormone treatment
Bilateral ovariectomy was performed by expert veterinar-
ians (SM and DM) using standard protocols. Beta-estradiol
(E, Sigma-Aldrich, Germany) stock for injections was
prepared by dissolving 1 mg estradiol in 100 μl of ethanol
and making up to 1 ml with sesame oil. 10 mg progester-
one (P, Sigma) was dissolved in 100 μl of chloroform and
final volume made to 1 ml by adding 900 μl of sesame oil.
Hormones were injected subcutaneously in a volume of
100 μl. Two weeks after bilateral ovariectomy, the mice
were subjected to various treatment schedules as shown in
Figure 1. Mice in Gp A received only sesame oil injections
and sacrificed on day 25 whereas Gp B, D & E were
initially primed by daily estradiol (100 ng/day) injec-
tions for 6 days (Day 14-19 after ovariectomy). Mice in
Gp B were injected estradiol (50 ng) on day 24 and
sacrificed 24 hrs later on day 25. Similarly mice in GpC
were injected progesterone (1 mg/Kg) on days 21-24
and sacrificed 24 hrs later on day 25. Gp D was initially
primed with estradiol and then injected progesterone
on days 21-24 along with estradiol (50 ng/day) on day
24 and then sacrificed on day 25. Mice in group E
received similar treatment as Gp D and were sacrificed
on day 27, 48 hrs after Gp D. Estradiol priming for six
days was essential as it is well known that progesterone
alone is incapable of expressing its own receptors [42].
The tissue collected after various treatments was proc-
essed appropriately to make uterine tissue cell smears,
for histology flow cytometry and RNA extraction. For-
malin fixed uterine tissue was processed and embedded
in paraffin using standard protocols. 5 μm thick sec-
tions were prepared and stained with Hematoxylin and
Eosin for studying the histo- architecture of uterus
after different hormonal administration. The represen-
tative areas were photographed and data recorded.
Smears preparation from uterine tissue
Briefly the uterine tissue was minced into small pieces
and then incubated with collagenase (1 mg/ml) & Trypsin
(1 mg/ml) and DNAse (0.5 mg/ml) in DMEM culture
media at 37°C for 30 minutes. After filtering through
40 μm filter, the filtrate was used to make smears. After
air drying, the smears were fixed in 4% PFA, washed 2-3
times with phosphate buffer saline (PBS), air dried and
stored at 4°C till further use. These smears were stained with
Hematoxylin and Eosin using standard method. The smears
were also stained with 4',6-diamidino-2-phenylindole,
dihydrochloride (DAPI) for few seconds to demonstrate
the presence of VSELs, as we know from our experienceon gonadal stem cells that VSELs (with abundant eu-
chromatin) do not stain easily with DAPI compared to
the progenitors [38] because of the presence of abun-
dant open euchromatin and DAPI selectively stains
specifically to A-T base pairs, producing a much stron-
ger signal on the heterochromatin than on the eu-
chromatin [43,44].
Enrichment of SCA-1 positive cells
Single cell suspension was prepared from uterine tissue
as described above. SCA-1 positive cells were immuno-
magnetically enriched using FITC tagged SCA-1 anti-
body and Easysep kit (Stem Cell Technology, Canada)
according to manufacturer’s instructions. Briefly 108
cells were immuno-stained with SCA-1 antibody (BD
Life Sciences, USA) for 15 minutes at room temperature
(RT), followed by incubation with FITC selection cock-
tail for 15 minutes. The cell suspension was then incu-
bated with magnetic nanoparticles for 10 minutes at RT
and placed on a magnetic particle concentrator. After
isolation, enriched SCA-1+ cells fraction as well as the
negative fraction were used for making smears and for
RNA extraction.
Immuno-staining of OCT-4 on smears
The cells smears were washed with PBS and then incu-
bated for 30 min in 3% hydrogen peroxide followed by
antigen retrieval in boiling sodium citrate saline buffer
of pH 6 for 5 min. After cooling, the smears were
washed with PBS for 5 min and then blocked with 10%
normal goat serum in PBS. After removing excess block-
ing reagent, the slides were incubated with primary anti-
body (polyclonal OCT4 from Millipore) for two hours at
room temperature. The detection was done using anti-
rabbit Vecta ABC kit (Vector Laboratories, USA) accord-
ing to manufacturer’s instructions. Color development was
done using 3,3' diaminobenzidine (DAB) (Biogenex, USA).
After counterstaining with Hematoxylin, the slides were
observed under Nikon 90i microscope. Representative
areas were photographed. Total protein isolated from
atrophied uterus was subjected to Western blotting for
OCT-4 (Additional file 1: Figure S2).
Immuno-fluorescence and confocal microscopy
SCA-1 sorted cells were used for studying expression of
OCT-4 by immuno-fluorescence. For this, following
washes with 0.5% BSA solution, the cells were perme-
abilized using 0.3% Triton-X 100 for 5 minutes. Blocking
was done with 3% BSA solution for 1 hour. Smears were
incubated with polyclonal OCT-4 antibody which stains
both the isoforms of OCT-4 (Abcam) at 4°C overnight.
Next day the smears were washed with wash buffer and
incubated with fluorescent tagged secondary alexafluor-
488 antibody for 2 hours at RT in dark. The slides were
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DAPI for 15 minutes. Images were captured by laser
scanning confocal microscope (Carl Zeiss, Germany).
RT-PCR and qRT-PCR studies
Details of primers used in the present study are shown
in Table 1.
RNA isolation and cDNA synthesis
The uterine tissue was collected in Trizol (Invitrogen,
Carlsbad, CA, USA) for RNA extraction by standard
protocol and then treated with DNase I (Amersham Bio-
sciences, Piscataway, NJ) at 37°C for 30 min to remove
any genomic DNA contamination. First-strand cDNA
was synthesized using the cDNA synthesis Kit (Bio-Rad,
USA) according to the manufacturer’s instructions.
Briefly, 1-2 μg of total RNA was incubated with 5X reac-
tion mix and reverse transcriptase mix. The reaction was
carried out in G-STORM thermocycler (Gene Technolo-
gies, Braintree, UK). The reaction mix was first incu-
bated at 25°C for 5 min, then at 42°C for 30 min and
finally at 85°C for 5 min. for cDNA synthesis.
RT-PCR for pluripotent stem cells specific markers: In
order to demonstrate the presence of VSELs by RT-PCR,
various transcripts (Oct4, Oct4A, Nanog, Sca1) were
amplified using a temperature gradient to establish the
optimal annealing temperature which varies from tissue
to tissue. Briefly, the cDNA mix (2 μl) was amplified
using 0.2 mM of each primer as described (Table 1),
1.25 unit of DreamTaq DNA polymerase (Fermentas) inTable 1 List of primer sequence used for RT-PCR and qRT-PCR


















R: TGCATTGCTGACAATCTTGAG1x Dream Taq buffer (Fermentas) and 0.2 mM dNTPs in
a G-STORM thermocycler. Amplification was carried
out for 35 cycles, with each cycle consisting of denatur-
ation at 94°C for 30 sec, annealing at the specified
temperature for each set of primers (Table 1) for 20 sec,
and extension at 72°C for 30 sec. The products were
analyzed on 2% agarose gel stained with 0.5 μg/ml
ethidium bromide (Bangalore Genei, India). The product
size was approximated using a 100-bp DNA ladder
(Bangalore Genei). The negative control did not include
cDNA in the reaction mixture and cDNA from mouse
ovary tissue was used as positive control.
Quantitative RT- PCR (qRT-PCR): Later, using the
standardized annealing temperature, qRT-PCR was car-
ried out to study how these transcripts are regulated by
steroid treatment. The expression levels of these gene
transcripts in relation to housekeeping gene transcript
18S were estimated by CFX96 real-time PCR system
(Bio-Rad Laboratories, USA) using SYBR Green chemis-
try (Bio-Rad). The amplification conditions included
initial denaturation at 94°C for 3 min followed by 40 -
cycles comprising of denaturation at 94°C for 30 seconds,
primer annealing for 20 sec and extension at 72°C for
30 sec. The final step included incubation at 94°C for
20 s to remove any secondary structures. The fluores-
cence emitted at each cycle was collected during the
extension step of each cycle. The homogeneity of the
PCR amplicons was verified by running the products
on 2% agarose gels and also by studying the melt curve.
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CFX Manager software (Bio-Rad) were used to calculate
the mRNA expression levels. Since ΔCt is inversely pro-
portional to relative mRNA expression levels, the levels
were calculated manually by the ΔCt method.
Results
Presence of VSELs in mouse uterus
H & E stained smears of uterine cell suspension clearly
showed the presence of very small sized cells with dark
Haematoxylin stained nucleus surrounded by a thinFigure 2 Detection of VSELs in mouse uterus. Panel A Hematoxylin and
the tissue. Note the presence of distinct spherical stem cells with dark stained
uterine cells have pale stained nucleus surrounded by abundant cytoplasm. P
figure. Scale bar represent 20 μm. Lower Panel B shows RT-PCR results for plu
ovariectomized uterus (Gp A). Results show that pluripotent stem cells exist inrim of cytoplasm (Figure 2A). These cells were distinct
from the somatic cells with pale stained nucleus sur-
rounded by abundant cytoplasm. The stem cells appear
similar to the VSELs reported by our group in testis
and ovary (Bhartiya et al., [9]). Flow cytometry studies
confirmed the presence of 0.0685% of LIN-/CD45-/
SCA-1+ VSELs in mouse uterus (Additional file 1:
Figure S1). RT-PCR analysis (Figure 2B) confirmed the
presence of pluripotent transcripts of expected size for
Oct4, Oct4A, Sca1 and Nanog in the ovariectomized
uterine tissue (Gp A).Eosin stained uterine smears prepared after enzymatic digestion of
nucleus with high nucleo-cytoplasmic ratio. In contrast, the somatic
lease note that 5-6 different fields have been combined to make this
ripotent markers Oct 4A, Nanog, Sca-1, Oct 4 and Gapdh in bilaterally
atrophied endometrium.
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Uterine cell suspension obtained by enzymatic digestion
was used to enrich SCA-1 positive VSELs. SCA-1 sorted
cells under fluorescent microscope showed very distinct
surface staining for SCA-1 (Figure 3A) and did not stain
with DAPI (Figure 3B) compared to somatic cells whichFigure 3 Characterization of uterine stem cells. A. SCA-1 sorted cells un
small sized cells which possibly are the very small embryonic-like stem cell
B. DAPI stained smear shows that the somatic cells negative for SCA-1 stain n
data was obtained for ovarian stem cells33; these cells do not stain with DAPI
chromatin. C. Higher magnification of OCT-4 stained cells with propidium iod
OCT-4. D. OCT-4 immuno-localization on the smears. Note the presence of tw
(asterix) and slightly bigger EnSCs. E. Nuclear versus cytoplasmic OCT-4 stainin
Scale bars represent 20 μm. Lower panel G shows the qRT-PCR results of neg
SCA-1 positive cells. As evident the stem cell markers Sca1, Oct 4A and Oct 4 awere stained with DAPI within 2 secs. These results are
similar to our earlier results where ovarian VSELs also
poorly stain with DAPI [38]. Immuno-localization for
OCT-4 on sorted stem cells showed the presence of two
distinct cell types expressing OCT-4 including few smaller
cells with nuclear OCT-4 and large number of cells withder microscope appear green and are of two distinct sizes including
s VSELs (asterix) and slightly bigger endometrial stem cells EnSCs.
icely with DAPI whereas the stem cells do not stain with DAPI. Similar
within 2-3 secs possibly because being pluripotent they have open
ide used as a counterstain shows cells have distinct nuclear staining of
o distinct sized cells which stain positive for OCT-4 including the VSELs
g can be clearly observed at higher magnification. F. Negative control.
ative (NEG) and positive (POS) fractions after immuno-magnetic sorting of
re highly enriched in the positive fraction.
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showed that the pluripotent transcripts (Sca-1, Oct-4A
and Oct-4) were enriched in the immuno-magnetically
positively sorted (POS) compared to the negative (NEG)
fraction suggesting that pluripotent VSELs do exist in
the uterus and can be sorted using SCA-1 (Figure 3,
bottom panel).
Thus above results showed the presence of LIN-/
CD45-/SCA + VSELs ranging in size from 3-5 μm with
nuclear OCT-4 and expressing Oct-4, Nanog and Sca-1
mRNA transcripts in mouse uterus. Two distinct sizes of
stem cells with nuclear OCT-4 in smaller VSELs and
slightly bigger cells with cytoplasmic OCT-4 were visual-
ized. The results are similar to the VSELs reported in
testis and ovary by our group. Interestingly the bigger
‘progenitors’ (immediate descendants of VSELs) with cyto-
plasmic OCT-4 are the spermatogonial stem cells (SSCs)
in testis, ovarian stem cells (OSCs/OGSCs) in ovary and
we term them as endometrial stem cells (EnSCs) in the
endometrium. Since we have observed EnSCs in smears,
their true shape and localization remains to be studied in
the endometrium. They could possibly be the cytoplasmic
OCT-4 positive mesenchymal cells described by several
groups in the endometrium [45,46].
Modulation of VSELs by hormones
Effect of steroid treatment on mouse uterus: As evident,
the uterus responded well to the treatment, being thin
and atrophied after bilateral ovariectomy and showed
variable morphology after various treatments (Figure 1).
Histology studies (Figures 4 & 5) showed expected
changes in the uterine histology with maximum atrophy
(evident by the size in cross-section) observed post
ovariectomy (Gp A). The uterus showed growth and ex-
tensive proliferation after estradiol treatment (Gp B) com-
pared to progesterone alone (Gp C). Combined estradiol
and progesterone (E + P) resulted in differentiation and
a receptive endometrium (Gp D) with characteristic
narrowing of lumen and secretory activity in the lumen.
Withdrawal of E + P for 48 hrs (after mice in Gp D were
sacrificed) resulted in extensive remodeling (Gp E) asso-
ciated with reduction in epithelial cell height (Figure 4).
At higher magnification (Figure 5) luminal epithelium
showed characteristic features of a receptive stage in Gp
D comprising of tall epithelial cells with oval shaped nuclei
in the middle, sub-nuclear vacuolation and secretory activ-
ity at the luminal surface. Whereas in Gp E the luminal
epithelial cells reduced in size due to withdrawal of hor-
mones resulting in increased nucleo-cytoplasmic ratio.
Increased vacuolation and apoptotic bodies (in luminal
and glandular epithelium as well as in the stromal com-
partment) could be observed at places, suggestive of
remodeling, repair and regeneration (Figure 5B-E). The
effect of steroid treatment at transcript level (Figure 5Lower panel) confirmed the histological findings. Pcna
(marker suggestive of DNA synthesis and proliferation)
showed minimal expression in Gps A and E (after ovari-
ectomy and during hormone withdrawal). Whereas it
was variably expressed in groups B-D. Bcl-2 was also
variably expressed in all groups whereas Bax transcripts
were observed only in Gp E. The ratio of Bax and Bcl-2
(suggestive of apoptosis) were increased in Gp E only
confirming that withdrawal of E + P for 48 hrs resulted
in remodeling of the endometrium and involved apop-
tosis. Thus we successfully obtained a mouse model to
study how VSELs are modulated in an atrophied endo-
metrium (Gp A), proliferative endometrium (Gp B com-
pared to Gp C), secretory endometrium (Gp D) and
endometrium which is undergoing remodeling and
regeneration (Gp E).
Quantitative RT-PCR studies for pluripotent markers
Oct-4A, Nanog and Sca-1 revealed an interesting pattern.
These transcripts were detected in all the groups however;
their expression was maximum in Gp A and E. Also Oct-4
(suggestive of the presence of ‘progenitors’ EnSCs) was
maximally expressed in the Gp D. It was interesting to
note that the ratio of Oct-4 to Oct-4A was equal in the
ovariectomized samples suggesting that stem cells in
ovariectomized sample mainly comprised of VSELs. In
contrast Oct-4 was more than ten-fold increase in Gp D
compared to a two-fold increase in Oct-4A, suggesting a
higher proportion of progenitors with cytoplasmic OCT-4
when the endometrium undergoes maximum growth/dif-
ferentiation and gets ready for implantation to occur.
Discussion
Different strategies have been employed by various investi-
gators to detect endometrial stem cells as shown in Table 2
but a clear picture of the true identity of endometrial
stem cells is yet to emerge. Present study for the first
time shows the presence of LIN-CD45-SCA+ very small
embryonic-like stem cells (VSELs) in the mouse uterus.
VSELs (comprising 0.07% of the total cell population as
judged by flow cytometry) were observed in uterine cell
smears and could be enriched by immuno-magnetic
sorting using a cell surface antigen SCA-1. Uterine
VSELs are small in size (3-5 μm), spherical in shape,
have high nucleo-cytoplasmic ratio, stain intensely with
Hematoxylin but poorly with DAPI and express nuclear
OCT-4, cell surface SCA-1 and pluripotent transcripts
including Oct4A, Sca1 and Nanog. Similar VSELs exist
in various adult mouse organs [1], human testes [39],
ovaries [38], bone marrow [2,47] and cord blood [48,49].
We succeeded to detect VSELs in uterine smears but
the exact location/niche of these cells in the uterus still
remains elusive because of their very small size and for
the same reason they have evaded the reproductive biol-
ogists till date.
Figure 4 (See legend on next page.)
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Figure 5 Higher magnification of uterine sections of Gp D and E. Luminal epithelium in Gp D (A) comprised tall, columnar cells with
centrally placed nuclei. Note the presence of secretory activity in the lumen. Withdrawal of E + P (C-D) resulted in reduction in epithelial cell
height with increased nucleo-cytoplasmic ratio and the nuclei were apically placed. The nuclei appeared more apical and signs for remodeling
and apoptotic bodies were evident in luminal and glandular epithelium and also in the stromal compartment. Scale bar represent 20 μm. Bottom
panel shows the qRT-PCR results of specific transcripts reflecting proliferation (Pcna) and apoptosis (Bax and Bcl2). As evident Pcna was minimally
expressed in Gp A and E whereas Bax and Bcl2 were unregulated in Gp E suggestive of increased apoptosis, in agreement with the histology data.
(See figure on previous page.)
Figure 4 Histology of mouse uterus of different treatment groups. A and F Ovariectomized GpA. B and G Estradiol alone GpB. C and H
Progesterone alone GpC D and I E + P GpD E, J and K E + P withdrawal GpE. As evident the ovariectomized uterus was atrophied (A) and the
cells were tightly packed (F) whereas estradiol treatment resulted in increased size of the uterus (B) with increased proliferation in both the
glands and stromal cells (G). Epithelial cells were tall and columnar and frequent mitotic figures were observed. Luminal epithelium appeared
highly folded, glands were also bigger and lot of edema in the stromal compartment. Progesterone treatment exerted minimal effect and the
uterus remained small in size (C) with densely packed cells (H). E + P treatment resulted in a receptive endometrium with characteristic narrowing of
uterine lumen (D), tall epithelial cells lined the lumen and the glands and lot of edema and increased vascularity was evident in the stromal
compartment. In contrast to the apically placed nuclei after estradiol treatment (G), in E + P treated section the nuclei are more centrally placed
(I), suggestive of a receptive condition when nutrients required for successful implantation shift to the apical end of the epithelial cells. Also
secretory activity was evident on the apical surface of luminal epithelial cells. Withdrawal of E + P resulted in repair and remodeling suggested
by the presence of a compacted uterus (E), small epithelial cells with increased nucleo-cytoplasmic ratio and dense compact stromal cells
(J & K). Scale bars represent 20 μm.
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Table 2 Various approaches utilized to detect and study
endometrial stem cells
Various approaches Salient observations and relevant references
Classic concept Stem cells may reside in the basal region of








Mouse LRCs decline with age, exist in lower
region of stroma and exhibit undifferentiated
markers including OCT-4 [25]
LRCs detected in luminal epithelium and
stromal cells adjacent to the luminal
epithelium [54] in mouse endometrium
LRCs detected only in the glandular epithelium
[22] in humans
Clonogenic assays Human endometrial stromal progenitor cells
can be cultured for more than 15 passages and
show high clonogenic efficiency (15%) [55]
Single endometrial stromal cell can form
cellular colonies that can be further serially
cloned and differentiated into various
mesodermal lineages [56]
Other relevant results Pluripotent markers have also been reported
in human endometrial and endometriotic
samples [27-30]
Bone marrow cells may be implicated in
endometrial repair [47,57]
Gunjal et al. Journal of Ovarian Research  (2015) 8:9 Page 11 of 15Besides the VSELs with nuclear OCT-4, we also detected
slightly bigger cells with cytoplasmic OCT-4 which we
term as the endometrial stem cells (EnSCs). These are
most likely the immediate multipotent descendants or
‘progenitors’ which arise by differentiation of pluripotent
VSELs and are expected to be multipotent and give rise to
various endometrial cell types. Differential OCT-4 expres-
sion pattern (obtained using a polyclonal antibody which
cross-reacts with both OCT-4A and OCT-4B isoforms)
has been very useful to differentiate between pluripotent
VSELs, the immediate descendants with cytoplasmic
OCT-4 and the differentiated progeny which show loss of
OCT-4. It is intriguing that similar VSELs exist in ovary,
testis, bone marrow and uterus but the immediate descen-
dants are distinct and give rise to different cell types based
on where the VSELs are located; spermatogonial stem cells
(SSCs) in testis differentiate to form the haploid sperm,
ovarian stem cells (OSCs) differentiate into haploid oo-
cytes, hematopoietic (HSCs) and mesenchymal (MSCs)
stem cells give rise to various kind of blood cells and simi-
larly the uterine stem cells (EnSCs) are expected to differ-
entiate into various endometrial cell types. Results suggest
that the microenvironment/niche where the VSELs are
located is crucial and dictates the fate of stem cells. We
recently reported that in mouse pancreas after partial
pancreatectomy – VSELs give rise to OCT-4 & PDX-1
co-expressing progenitors which then differentiate andgive rise to both the beta and acinar cells [58]. Ability of
VSELs to give rise to SSCs, OSCs, HSCs, MSCs, EnSCs
and pancreatic progenitors reflects their pluripotent state.
Ability of VSELs to give rise to three germ layers has
already been reported in mice [6] and humans [7]. Further
detailed studies are required to understand stem cells-
niche interaction as recently suggested [59,60].
Two stem cell populations comprising of a quiescent and
actively dividing stem cells have been reported in adult
somatic tissues including gut epithelium, hair follicle, bone
marrow etc. [11,12]. Similarly we have found that VSELs are
the quiescent stem cells in the testis and ovaries whereas
the SSCs and OGSCs divide rapidly and undergo clonal
expansion prior to initiating differentiation [9,10]. That
VSELs comprise the quiescent population of stem cells gets
further credence from the reports showing that they survive
chemotherapy in mice testis [18], ovary [19] and total body
irradiation in bone marrow [17] whereas the actively divid-
ing progenitors are destroyed. These findings are intriguing
and suggest that VSELs could be the quiescent stem cell
population in various adult organs. VSELs have also been
implicated in cancers [61] and are possibly the elusive
cancer-initiating cells responsible for recurrence (as they are
likely to be spared of oncotherapy because of their quiescent
nature). Further studies are required to investigate this.
Cells with cytoplasmic OCT-4 and other pluripotent
transcripts have been reported by various investigators
in mouse as well as human endometrial and endometriotic
tissue [32-35]. There exists lot of confusion because these
studies have failed to distinguish and appreciate the
relevance of cytoplasmic versus nuclear OCT-4 staining
[36,37]. The small sub-population of VSELs with nuclear
OCT-4 remained undetected in the mouse uterus till now
possibly because they exist in very few numbers, are of very
small size and also because VSELs tend to get lost during
processing as suggested earlier while studying cord blood
and bone marrow stem cells [48]. Mesenchymal stem cells
have been reported in the endometrium [45,46]. It has been
suggested that the MSCs (negative for CD45, CD34 and
positive for CD146, PDGF-receptor-Beta, CD29, CD44,
CDE73, CD90 and CD105) get further differentiated into
stromal and glandular cells. Evidence to support that VSELs
may give rise to the MSCs has been elegantly demonstrated
by Taichman et al. [62] wherein they reported that Sca+Lin-
CD45- cells could differentiate into multiple mesenchymal
lineages in their study model. Similarly in umbilical cord
tissue we have earlier reported that VSELs (with nuclear
OCT-4) and MSCs (with cytoplasmic OCT-4) co-exist in
the Wharton’s jelly [48]. Existence of two stem cell popula-
tions has also been postulated in the endometrium [54] and
the endometrial stromal cells are considered lineage cells of
endometrial mesenchymal stem cells.
Results of the present study further show that uterine
VSELs and the progenitors EnSCs are implicated during
Gunjal et al. Journal of Ovarian Research  (2015) 8:9 Page 12 of 15endometrial atrophy, growth and remodeling/regeneration.
Presence of VSELs in ovariectomized atrophied uterus is in
agreement with earlier report that a pool of stem cellsFigure 6 qRT-PCR results for pluripotent transcripts showing variable
markers for VSELs) and Oct-4 (all Oct-4 transcripts including Oct-4B indicati
transcripts are observed in all the treated groups suggesting presence of st
They are up-regulated in GpA, compared to Gp B and C and are maximally
GpD suggesting presence of EnSCs. Note the scale of Y-axis to appreciate d
in atrophic endometrium and stem cells activity is greatly increased in E +
GpE associated with remodeling and repair. Ratio of Oct-4 to Oct-4A is alm
GpD the ratio is greatly increased suggesting presence of large number of pro
and error bars represent standard error.remains preserved even in atrophic endometrium [63].
Oct-4A and Oct-4 transcripts were equally expressed in
Gp A (Figure 6) suggesting that stem cell populationeffects of hormone treatment. Oct-4A, Nanog, Sca-1 (pluripotent
ng presence of EnSCs) in various treatment groups. The pluripotent
em cells in all the conditions, but are modulated by steroid treatment.
expressed in Gp D and E. Oct-4 is more than 10 fold increased in
ifferences between groups. Results suggest that stem cells are present
P group when maximum growth is observed and remain elevated in
ost 1 in GpA suggesting most of stem cells are the VSELs whereas in
genitors. Results are compilation of more than three biological samples
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ever they are unable to differentiate possibly because of
a compromised microenvironment/niche, a situation
similar to presence of VSELs in chemoablated testis and
ovary [18,19]. VSELs and EnSCs are present in the
uterus in the E and P treated groups but their numbers
are greatly increased in E + P and the withdrawal group.
Total Oct-4 transcript is 5-15 fold increase compared to
Oct-4A suggesting rapid expansion of progenitors (EnSCs)
under these conditions. VSELs give rise to EnSCs which
multiply in large numbers and further differentiate into
various cell types to bring about growth (Gp D) and
remodeling/regeneration (Gp E) of endometrium. In the
past, stem cells have been implicated in the process of
endometrium remodeling, regeneration and also during
various disease conditions like endometriosis and endo-
metrial hyperplasia, carcinoma, leiomyomas and adeno-
myosis [22]. Thus it becomes pertinent to use a more
quantitative approach like flow cytometry and other
cellular and molecular techniques to evaluate VSELs
and EnSCs in the endometrial tissue from normal and
various pathological conditions. Similar to modulation
of endometrial VSELs by steroid hormones, VSELs in
adult mammalian ovaries are modulated by follicle
stimulating hormone [13-16].
Several studies [64,65] suggest that stem cells (isolated
as side population SP cells which efflux Hoechst 33342
and also express CD133) from normal endometrium may
be involved in the development of endometrial cancer.
Kato et al. [66] provided first direct evidence to support
that SP cells contribute to endometrial carcinogenesis and
are associated with elevated OCT-4 expression. Endomet-
rial hyperplasia (considered as a precursor to endometrial
cancer) was observed in mice after neonatal exposure to
estradiol and VSELs altered biology was implicated [67].
Thus it is likely that the VSELs which exist in normal
endometrium are possibly the embryonic remnants re-
sponsible for initiation of endometrial cancer as has been
proposed earlier [61].
Engraftment of donor cells in the endometrium (in both
glands and stroma) has been reported in women undergo-
ing single-antigen, HLA-mismatched, bone marrow trans-
plantation and also in mice [57,68,69]. Nagori et al. [57]
reported beneficial effect of autologus bone marrow cell
transplantation in case of Asherman syndrome. Gargett
and Healy [70] suggested that main mechanism resulting
in beneficial effect of bone marrow cells demonstrated by
Nagori’s group, could possibly be to improve the niche
rather than true regeneration. Resident stem cells may
play a major role in regeneration rather than the bone
marrow cells because the engraftment of XY donor de-
rived cells of bone marrow origin has been found to be
very poor (<10%) in endometrial glands and stroma [71].
Zhao et al. [72] reported that intrauterine transplantationof autologus bone marrow derived mesenchymal stem
cells in women with Asherman’s syndrome resulted in
conception. Similarly, Alawadhi et al. [73] reported that
transplantation of bone marrow derived stem cells can
regenerate mouse model of Asherman’s syndrome and
improve fertility rates. Available literature suggests that
VSELs are mobilized whenever any organ function is
compromised [74-78] and thus endogenous VSELs are ex-
pected to be present in the uterus affected by Asherman’s
syndrome (similar to their presence in atrophied endomet-
rium in the present study, Gp A). Transplanted bone
marrow stem cells act as a source of growth factors/cyto-
kines thus facilitating endogenous VSELs to regenerate
the damaged endometrium. In addition, few transplanted
stem cells may also get involved in regeneration and thus
Y chromosome positive cells in both stromal and epithelial
compartment have been reported by Alawadhi et al. [73].
This highlights the fact that a similar stem cell population
exists in the endometrium and bone marrow stem cells.
Similar to improvement of the thin endometrium by
transplanting bone marrow stem cells, surviving endogen-
ous VSELs in chemoablated testis underwent differen-
tiation (spermatogenesis) when a healthy niche was
provided by way of transplanting healthy Sertoli or mesen-
chymal cells [18]. We speculate that if the uterine function
of the mice (with Y chromosome positive cells engrafted
after transplantation) is compromised by subjecting the
mice to bilateral ovariectomy or by any other means
(thereby creating regenerative pressure), one may observe
clonal expansion, differentiation and increased numbers of
Y chromosome bearing cells. Further studies need to be
undertaken to delineate endogenous stem cells biology
and also Y chromosome bearing cells.
To conclude, we have shown for the first time the pres-
ence of two stem cell populations in mouse uterus includ-
ing pluripotent VSELs and their immediate descendants
EnSCs. Data has also been generated to show that these
stem cells are modulated by hormones and thus play an im-
portant role during endometrial growth and regeneration.
VSELs could also be the cancer initiating cells in the endo-
metrium. Further studies are urgently required to study
VSELs and EnSCs during endometrial normal biology, can-
cer and other pathologies.
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